Low Leverage / Manageable DebtLow absolute debt and improved leverage provide durable financial flexibility while cash burn continues. With minimal near-term interest obligations the company has more runway to prioritize R&D, partnerships or restructuring without immediate refinancing pressure, reducing insolvency risk.
Positive Gross ProfitSustained positive gross margins indicate the core products or manufacturing economics can cover direct costs. That underlying unit-level profitability is a durable foundation — if SG&A is controlled and volumes recover, operating leverage could lead to a sustainable path toward break-even.
Industry ExposureOperating in specialty and generic pharmaceuticals offers structural demand from aging populations and recurring prescription patterns. This sector supports long-term revenue durability, opportunities for niche leadership, and recurring cash flows if commercialization and regulatory pathways succeed.